These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11978661)

  • 1. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.
    Freeman DJ; Norrie J; Caslake MJ; Gaw A; Ford I; Lowe GD; O'Reilly DS; Packard CJ; Sattar N;
    Diabetes; 2002 May; 51(5):1596-600. PubMed ID: 11978661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.
    Sattar N; Scherbakova O; Ford I; O'Reilly DS; Stanley A; Forrest E; Macfarlane PW; Packard CJ; Cobbe SM; Shepherd J;
    Diabetes; 2004 Nov; 53(11):2855-60. PubMed ID: 15504965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
    Sattar N; Gaw A; Scherbakova O; Ford I; O'Reilly DS; Haffner SM; Isles C; Macfarlane PW; Packard CJ; Cobbe SM; Shepherd J
    Circulation; 2003 Jul; 108(4):414-9. PubMed ID: 12860911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.
    Thorand B; Löwel H; Schneider A; Kolb H; Meisinger C; Fröhlich M; Koenig W
    Arch Intern Med; 2003 Jan; 163(1):93-9. PubMed ID: 12523922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Diabetes Care; 2005 Oct; 28(10):2525-30. PubMed ID: 16186291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.
    Laaksonen DE; Niskanen L; Nyyssönen K; Punnonen K; Tuomainen TP; Valkonen VP; Salonen R; Salonen JT
    Diabetologia; 2004 Aug; 47(8):1403-10. PubMed ID: 15309290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile.
    Asegaonkar SB; Marathe A; Tekade ML; Cherekar L; Bavikar J; Bardapurkar J; Ajay R
    J Diabetes Complications; 2011; 25(6):368-70. PubMed ID: 22055258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.
    Friedman AN; Hunsicker LG; Selhub J; Bostom AG;
    Kidney Int; 2005 Aug; 68(2):773-8. PubMed ID: 16014055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm.
    Sever PS; Poulter NR; Chang CL; Thom SA; Hughes AD; Welsh P; Sattar N;
    J Am Coll Cardiol; 2013 Aug; 62(8):717-29. PubMed ID: 23948514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
    Han TS; Sattar N; Williams K; Gonzalez-Villalpando C; Lean ME; Haffner SM
    Diabetes Care; 2002 Nov; 25(11):2016-21. PubMed ID: 12401749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
    Festa A; D'Agostino R; Tracy RP; Haffner SM;
    Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.
    Godsland IF; Elkeles RS; Feher MD; Nugara F; Rubens MB; Richmond W; Khan M; Donovan J; Anyaoku V; Flather MD;
    Diabet Med; 2006 Nov; 23(11):1192-200. PubMed ID: 17054594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study.
    Doi Y; Kiyohara Y; Kubo M; Ninomiya T; Wakugawa Y; Yonemoto K; Iwase M; Iida M
    Diabetes Care; 2005 Oct; 28(10):2497-500. PubMed ID: 16186286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up.
    Wang C; Yatsuya H; Tamakoshi K; Uemura M; Li Y; Wada K; Yamashita K; Kawaguchi L; Toyoshima H; Aoyama A
    Diabetes Metab Res Rev; 2013 Jul; 29(5):398-405. PubMed ID: 23463453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians.
    Wang Z; Hoy WE
    Diabetes Res Clin Pract; 2007 Apr; 76(1):37-43. PubMed ID: 16952410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of type 2 diabetes attributable to C-reactive protein and other risk factors.
    Dehghan A; van Hoek M; Sijbrands EJ; Stijnen T; Hofman A; Witteman JC
    Diabetes Care; 2007 Oct; 30(10):2695-9. PubMed ID: 17623828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study.
    Sattar N; McConnachie A; O'Reilly D; Upton MN; Greer IA; Davey Smith G; Watt G
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):583-7. PubMed ID: 14739124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.